RE:TRIP Absolutely agreed, I am long as well, ~25,000 shares @ $0.14 - $0.15. In my opinion TRIP is a very good long term investment, because psilocybin's therapeutic/medicinal potential alone is very, very serious. That's not even including a responsibly-enjoyed recreational market. The Netherlands is ahead of the curve as a pioneer of this product within what is a nascent industry poised for a lot of growth. Success should be relatively easy for this company to accomplish.